TipRanks on MSN
Dogwood to present on Halneuron pain research program
Therapeutics announced that its Chief Medical Officer will present an overview of the Halneuron pain management research program at ...
Muna Therapeutics ApS has disclosed new potassium voltage-gated channel subfamily A member 3 (KCNA3, Kv1.3) channel blockers reported to be useful for the treatment of cancer, neurodegeneration, ...
Humanwell Pharmaceutical US Inc. has disclosed new potassium voltage-gated channel subfamily KQT member 2 (KCNQ2; Kv7.2) and Kv7.3 activators. They are described as potentially useful for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback